Commercially insured patients taking opioids for chronic pain pay absolutely nothing out of pocket for EVZIO through the direct-delivery service*

Committed to affordability

Committed to affordability

  • Through the direct-delivery service, no other naloxone product, branded or generic, is more affordable than EVZIO for commercially insured patients
  • All commercially insured patients pay absolutely nothing out of pocket, regardless of coverage, copays, or deductible payments*

Only valid for commercially insured patients in the 50 United States and DC through the direct delivery service. Not eligible if prescriptions are paid for in part/full by state or federally funded program(s), like Medicare Part D, Medicaid, Vet. Aff., Dept. of Def., or Tricare, and where prohibited by law. OFFER IS NOT INSURANCE. Offer cannot be sold, purchased, traded, transferred, and cannot be combined with any other offer. Offer may change at any time, without notice. Call (877) 438-9463 for questions regarding eligibility.

Ease of fulfillment

Ease of fulfillment

  • Enrollment is as simple as providing a prescription and demographic information. The pharmacy, which is trained on the EVZIO2YOU access program, ensures that the prescription is processed quickly and properly
  • The direct-delivery service delivers EVZIO to the patient’s home or to your office with free shipping
Comprehensive naloxone access

Comprehensive naloxone access

  • Many patients with government insurance may get EVZIO at no cost. If the patient decides the cost is not affordable, the pharmacy may work with the patient’s healthcare provider to offer an alternative naloxone

Find a Pharmacy

Our goal is to help ensure that your patients and their care partners have access to naloxone.

Map

EVZIO fulfillment through EVZIO2YOU direct-delivery service

EVZIO fulfillment through EVZIO2YOU direct-delivery service

For questions about EVZIO2YOU, call 1-855-77-EVZIO (1-855-773-8946) Monday through Saturday, 8 am to 8 pm ET

INDICATION

EVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adults and pediatric patients. EVZIO is intended for immediate administration as emergency therapy in settings where opioids may be present. EVZIO is not a substitute for emergency medical care.

IMPORTANT SAFETY INFORMATION

EVZIO is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the ingredients in EVZIO.

Seek emergency medical assistance immediately after use. Additional supportive and/or resuscitative measures may be helpful while awaiting emergency medical assistance.

The following warnings and precautions should be taken when administering EVZIO:

The following adverse reactions were most commonly observed in EVZIO clinical studies: dizziness and injection site erythema.

Abrupt reversal of opioid effects in persons who were physically dependent on opioids has precipitated signs and symptoms of opioid withdrawal including: body aches, fever, sweating, runny nose, sneezing, piloerection, yawning, weakness, shivering or trembling, nervousness, restlessness or irritability, diarrhea, nausea or vomiting, abdominal cramps, increased blood pressure, and tachycardia. In the neonate, opioid withdrawal signs and symptoms also included: convulsions, excessive crying, and hyperactive reflexes.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click for full Prescribing Information and Patient Information.

Indication

EVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adults and pediatric patients. EVZIO is intended for immediate administration as emergency therapy in settings where opioids may be present. EVZIO is not a substitute for emergency medical care.

Important Safety Information

EVZIO is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the ingredients in EVZIO.

INDICATION

EVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adults and pediatric patients. EVZIO is intended for immediate administration as emergency therapy in settings where opioids may be present. EVZIO is not a substitute for emergency medical care.

Important Safety Information

EVZIO is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the ingredients in EVZIO.

INDICATION

EVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adults and pediatric patients. EVZIO is intended for immediate administration as emergency therapy in settings where opioids may be present. EVZIO is not a substitute for emergency medical care.

IMPORTANT SAFETY INFORMATION

EVZIO is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the ingredients in EVZIO.